Tuesday, April 16, 2024

Tuesday, April 16, 2024

Organization Directory

Refine Your Search U.S. Associations 2

Type:

Filter by Org Category:

Filter By Name:


Trending

  1. 1 ASTELLAS PHARMA INC.: FDA Accepts for Priority Review the New Drug Application for mirabegron for Oral Suspension and Supplemental New Drug Application for Myrbetriq® (mirabegron) Tablets in Pediatric Patients
  2. 2 FORGE BIOLOGICS: Announces FDA Clearance of Investigational New Drug Application for Phase 1/2 Clinical Trial (RESKUE) of FBX-101 Gene Therapy for Patients with Krabbe Disease
FDA Reporter